Literature DB >> 18461285

Epithelial mesenchymal transition traits in human breast cancer cell lines.

T Blick1, E Widodo, H Hugo, M Waltham, M E Lenburg, R M Neve, E W Thompson.   

Abstract

Epithelial mesenchymal transition (EMT) has long been associated with breast cancer cell invasiveness and evidence of EMT processes in clinical samples is growing rapidly. Genome-wide transcriptional profiling of increasingly larger numbers of human breast cancer (HBC) cell lines have confirmed the existence of a subgroup of cell lines (termed Basal B/Mesenchymal) with enhanced invasive properties and a predominantly mesenchymal gene expression signature, distinct from subgroups with predominantly luminal (termed Luminal) or mixed basal/luminal (termed Basal A) features (Neve et al Cancer Cell 2006). Studies providing molecular and cellular analyses of EMT features in these cell lines are summarised, and the expression levels of EMT-associated factors in these cell lines are analysed. Recent clinical studies supporting the presence of EMT-like changes in vivo are summarised. Human breast cancer cell lines with mesenchymal properties continue to hold out the promise of directing us towards key mechanisms at play in the metastatic dissemination of breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18461285     DOI: 10.1007/s10585-008-9170-6

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  97 in total

1.  LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.

Authors:  Erik W Thompson; Mark Waltham; Susan J Ramus; Anne-Marie Hutchins; Jane E Armes; Ian G Campbell; Elizabeth D Williams; Phillip R Thompson; James M Rae; Michael D Johnson; Robert Clarke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 2.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

Review 3.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

4.  Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer.

Authors:  H-F Yuen; C-W Chua; Y-P Chan; Y-C Wong; X Wang; K-W Chan
Journal:  Histopathology       Date:  2007-04       Impact factor: 5.087

5.  Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

Authors:  Christine H Chung; Joel S Parker; Kim Ely; Jesse Carter; Yajun Yi; Barbara A Murphy; K Kian Ang; Adel K El-Naggar; Adam M Zanation; Anthony J Cmelak; Shawn Levy; Robbert J Slebos; Wendell G Yarbrough
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

6.  Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.

Authors:  S M Maira; J M Wurtz; B Wasylyk
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

7.  A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients.

Authors:  Virginie N Dupont; David Gentien; Marine Oberkampf; Yann De Rycke; Nathalie Blin
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396

Review 8.  The role of epithelial-to-mesenchymal transition in renal fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2004-01-30       Impact factor: 4.599

9.  A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines.

Authors:  D T Ross; C M Perou
Journal:  Dis Markers       Date:  2001       Impact factor: 3.434

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  165 in total

1.  Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.

Authors:  Rebecca A Whipple; Michael A Matrone; Edward H Cho; Eric M Balzer; Michele I Vitolo; Jennifer R Yoon; Olga B Ioffe; Kimberly C Tuttle; Jing Yang; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.

Authors:  Sarah Jurmeister; Marek Baumann; Aleksandra Balwierz; Ioanna Keklikoglou; Aoife Ward; Stefan Uhlmann; Jitao David Zhang; Stefan Wiemann; Özgür Sahin
Journal:  Mol Cell Biol       Date:  2011-12-05       Impact factor: 4.272

3.  Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues.

Authors:  Kun Yuan; Natalya Frolova; Yi Xie; Dezhi Wang; Leah Cook; Yeon-Jin Kwon; Adam D Steg; Rosa Serra; Andra R Frost
Journal:  J Histochem Cytochem       Date:  2010-06-07       Impact factor: 2.479

4.  Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing.

Authors:  Kimberly A Dittmar; Peng Jiang; Juw Won Park; Karine Amirikian; Ji Wan; Shihao Shen; Yi Xing; Russell P Carstens
Journal:  Mol Cell Biol       Date:  2012-02-21       Impact factor: 4.272

5.  An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition.

Authors:  Claude C Warzecha; Peng Jiang; Karine Amirikian; Kimberly A Dittmar; Hezhe Lu; Shihao Shen; Wei Guo; Yi Xing; Russ P Carstens
Journal:  EMBO J       Date:  2010-08-13       Impact factor: 11.598

Review 6.  Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.

Authors:  Tony Blick; Honor Hugo; Edwin Widodo; Mark Waltham; Cletus Pinto; Sendurai A Mani; Robert A Weinberg; Richard M Neve; Marc E Lenburg; Erik W Thompson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-06-04       Impact factor: 2.673

7.  Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.

Authors:  Claudia Palena; Mario Roselli; Mary T Litzinger; Patrizia Ferroni; Leopoldo Costarelli; Antonella Spila; Francesco Cavaliere; Bruce Huang; Romaine I Fernando; Duane H Hamilton; Caroline Jochems; Kwong-Yok Tsang; Qing Cheng; H Kim Lyerly; Jeffrey Schlom; Fiorella Guadagni
Journal:  J Natl Cancer Inst       Date:  2014-05-09       Impact factor: 13.506

8.  Correlation of Forkhead Box c2 with subtypes and invasive ability of invasive breast cancer.

Authors:  Jun Dai; Jin-Yu Wang; Li-Li Yang; Ying Xiao; Zhi-Ling Qu; Sheng-Hui Qin; Qiu-Rong Ruan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

9.  Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines.

Authors:  Edward H Cho; Rebecca A Whipple; Michael A Matrone; Eric M Balzer; Stuart S Martin
Journal:  Cancer Biol Ther       Date:  2010-01-28       Impact factor: 4.742

10.  Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Authors:  Begoña Martin-Castillo; Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Silvia Cufí; José Manuel Moreno; Bruna Corominas-Faja; Ander Urruticoechea; Ángel G Martín; Eugeni López-Bonet; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.